Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Science

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2006.00203.xPMID 16734726PMCID PMC11159019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Diagnosis

  2005cited by this paper
• Down-regulation of Human DAB2IP Gene Expression Mediated by Polycomb Ezh2 Complex and Histone Deacetylase in Prostate Cancer*

  2005cited by this paper
• Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas.

  2005cited by this paper
• Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma

  2005cited by this paper
• Polycomb group protein ezh2 controls actin polymerization and cell signaling.

  2005cited by this paper
• Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

  2005cited by this paper
• Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A

  2004cited by this paper
• Focus on the histologic diversity in primary and lymph node lesions and the outcome of gastric cancer.

  2004cited by this paper
• Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

  2004cited by this paper
• Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.

  2004cited by this paper
• Pathologic characteristics of gastric cancer in the elderly: a retrospective study of 994 surgical patients

  2004cited by this paper
• The actin cytoskeleton in normal and pathological cell motility.

  2004cited by this paper
• Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.

  2004cited by this paper
• The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

  2004cited by this paper
• EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

  2003cited by this paper
• Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

  2003cited by this paper
• EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer

  2003cited by this paper
• Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

  2003cited by this paper
• Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer

  2003cited by this paper
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

  2002cited by this paper
• Early gastric carcinoma with signet ring cell histology

  2002cited by this paper
• Histone methyltransferase activity of a Drosophila Polycomb group repressor complex.

  2002cited by this paper
• The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?

  2002cited by this paper
• Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites.

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002influential reference
• Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

  2002cited by this paper
• Molecular diagnosis of gastric cancer: present and future

  2001cited by this paper
• Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers.

  2001cited by this paper
• Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

  2001cited by this paper
• Genetic and epigenetic changes in stomach cancer.

  2001cited by this paper
• Physical and functional association of SU(VAR)3‐9 and HDAC1 in Drosophila

  2001cited by this paper
• The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

  2001cited by this paper
• Pathology and prognosis of gastric carcinoma

  2000cited by this paper
• Present and Future

  2000cited by this paper
• Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.

  2000cited by this paper
• Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma

  1999cited by this paper
• Molecular–pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology

  1999cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper
• Prognostic factors in adenocarcinoma of the gastric cardia: pathologic stage analysis and multivariate regression analysis.

  1997cited by this paper
• Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2.

  1996cited by this paper
• Surgical aspects of patients with adenocarcinoma of the stomach operated on for cure.

  1996cited by this paper
• Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients

  1994cited by this paper
• Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract.

  1993cited by this paper
• Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.

  1991cited by this paper
• COMPARISON OF SEVEN CELL LINES DERIVED FROM HUMAN GASTRIC CARCINOMAS

  1986cited by this paper
• Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1.

  1985cited by this paper

• Dual Effect of EZH2 Gene Editing with CRISPR/Cas9 in Lung Cancer

  2026cites this paper
• Non-catalytic role of SETD1A promotes gastric cancer cell proliferation through the E2F4–TAF6 axis in the cell cycle

  2025cites this paper
• Phosphorylation event changes the RNA binding mode of EZH2 disordered segment

  2025cites this paper
• EZH2 Dysregulation and Its Oncogenic Role in Human Cancers

  2025cites this paper
• An updated patent review of EZH2 inhibitors (2024–present)

  2025cites this paper
• Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities

  2024cites this paper
• Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities

  2023cites this paper
• Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC)

  2023cites this paper
• Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies

  2023cites this paper
• Association of EZH2 Genotypes With Oral Cancer Risk

  2022cites this paper
• Upregulated Circular RNA KIF4A Promotes Cell Migration and Invasion by Regulating MicroRNA-144-3p/EZH2 Axis in Gastric Cancer

  2022cites this paper
• H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes

  2022cites this paper
• Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases

  2021cites this paper
• Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity

  2021cites this paper
• EZH2-mediated epigenetic suppression of lncRNA PCAT18 predicts a poor prognosis and regulates the expression of p16 by interacting with miR-570a-3p in gastric cancer

  2021cites this paper
• Downregulation of circ-PSMB6 suppresses NSCLC progression and metastasis through sponging miR-532-5p and regulating EZH1 expression

  2021cites this paper
• Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

  2021cites this paper
• Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer

  2021cites this paper
• Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation

  2021cites this paper
• Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells

  2020cites this paper
• Glycyrrhiza glabra suppresses nasopharyngeal carcinoma cell proliferation through inhibiting the expression of lncRNA, AK027294

  2020cites this paper
• Elevated expression of RUNX3 co-expressing with EZH2 in esophageal cancer patients from India

  2020cites this paper
• Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer.

  2020cites this paper
• miR-144-3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2

  2020cites this paper
• An LCM-based genomic analysis of SPEM, Gastric Cancer and Pyloric Gland Adenoma in an Asian cohort

  2020cites this paper
• Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities

  2020cites this paper
• Carcinogenic roles and therapeutic effects of EZH2 in gynecological cancers.

  2020cites this paper
• Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms

  2019cites this paper
• OTT_A_210376 7513..7525

  2019influential citation
• Circular RNA TTBK2 promotes the development of human glioma cells via miR-520b/EZH2 axis.

  2019cites this paper
• Vinculin promotes gastric cancer proliferation and migration and predicts poor prognosis in patients with gastric cancer

  2019cites this paper
• MicroRNA-31 triggers G2/M cell cycle arrest, enhances the chemosensitivity and inhibits migration and invasion of human gastric cancer cells by downregulating the expression of zeste homolog 2 (ZH2).

  2019cites this paper
• Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression

  2019cites this paper
• GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells

  2019cites this paper
• Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

  2019cites this paper
• Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer

  2019influential citation
• Clinical and biological significance of EZH2 expression in endometrial cancer

  2019cites this paper
• Cancer as a tissue: The significance of cancer‐stromal interactions in the development, morphogenesis and progression of human upper digestive tract cancer

  2018cites this paper
• Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer

  2018cites this paper
• An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma.

  2018cites this paper
• High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors

  2018cites this paper
• Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2

  2018influential citation
• UNFOLDING THE GENETIC SECRETS OF GASTRIC CARCINOGENESIS

  2018cites this paper
• Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.

  2018cites this paper
• EZH2 overexpression in head and neck cancer is related to lymph node metastasis

  2018cites this paper
• Emerging EZH2 Inhibitors and Their Application in Lymphoma

  2018cites this paper
• Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer

  2018cites this paper
• Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis

  2018cites this paper
• The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter

  2018cites this paper
• EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer

  2018cites this paper
• DNA and Histone Methylation as Cancer Targets

  2017influential citation
• DNA methylation inhibitor causes cell growth retardation and gene expression changes in feline lymphoma cells

  2017cites this paper
• Naturally occurring anti-cancer agents targeting EZH2.

  2017cites this paper
• Polycomb group expression signatures in the malignant progression of gliomas

  2017cites this paper
• Targeting Histone Methylation in Cancer.

  2017cites this paper
• Misregulation of Histone Methylation Regulators in Cancer

  2017cites this paper
• Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.

  2017cites this paper
• Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression

  2017cites this paper
• Enhancement of death receptor-mediated apoptosis in multiple myeloma cells

  2017cites this paper
• Polycomb Repressor Complex 2 in Genomic Instability and Cancer

  2017cites this paper
• Etude du rôle des protéines Polycomb Pcgf1 et Ezh2 chez le poisson zèbre Danio rerio

  2017cites this paper
• EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma

  2016cites this paper
• Prognostic value of UTX expression in patients with clear cell renal cell carcinoma.

  2016cites this paper
• Theanine from tea and its semi-synthetic derivative TBrC suppress human cervical cancer growth and migration by inhibiting EGFR/Met-Akt/NF-κB signaling.

  2016cites this paper
• Down-Regulation of TSLP After EZH2 Silencing in ESCC Cell Line

  2016cites this paper
• Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer

  2016cites this paper
• Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression

  2016cites this paper
• GSK3BETA-MEDIATED EZH2 PHOSPHORYLATION SUPPRESSES METHYLATION OF H3K27 AND EZH2’S ONCOGENIC FUNCTIONS

  2016cites this paper
• Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.

  2016cites this paper
• Synergistic antineoplastic action of 5-aza-2'deoxycytidine (decitabine) in combination with different inhibitors of enhancer of zeste homolog 2 (EZH2) on human lung carcinoma cells

  2016cites this paper
• Single Nucleotide Polymorphism of the Enhancer of Zeste Homolog 2 Gene rs2072408 is Associated with Lymph Node Metastasis and Depth of Primary Tumor Invasion in Gastric Cancer.

  2016cites this paper
• Histone Modifications as Molecular Targets in Nasopharyngeal Cancer.

  2016cites this paper
• Gastric cancer pathogenesis

  2016cites this paper
• Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review.

  2016cites this paper
• The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway

  2016cites this paper
• Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta‐analysis

  2016cites this paper
• Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer

  2016cites this paper
• Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer

  2016cites this paper
• EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis

  2016cites this paper
• Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells

  2016cites this paper
• Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis

  2016cites this paper
• Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2

  2016cites this paper
• Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma

  2015cites this paper
• microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer

  2015cites this paper
• Targeting Head and Neck Cancer Stem Cells

  2015cites this paper
• LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer

  2015cites this paper
• Emerging Epigenetic Therapies—Lysine Methyltransferase/PRC Complex Inhibitors

  2015cites this paper
• Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16

  2015cites this paper
• Targeting EZH2 for Cancer Therapy: Progress and Perspective

  2015cites this paper
• EZH2 Mediates the Regulation of S100A4 on E-cadherin Expression and the Proliferation, Migration of Gastric Cancer Cells.

  2015cites this paper
• EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.

  2015cites this paper
• MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.

  2015cites this paper
• Cancer type-specific epigenetic changes: gastric cancer.

  2015cites this paper
• Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation.

  2015cites this paper
• Prognostic significance of EZH2 expression in patients with digestive cancers: a meta-analysis.

  2015cites this paper
• EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB‐1 proliferation index

  2015cites this paper
• Diverse involvement of EZH 2 in cancer epigenetics

  2015cites this paper
• pRb2/p130 Localizes to the Cytoplasm in Diffuse Gastric Cancer

  2015cites this paper
• Diverse involvement of EZH2 in cancer epigenetics.

  2015cites this paper
• EZH2 is a sensitive marker of malignancy in salivary gland tumors

  2015cites this paper